nationsobserver.com

Nation Observer

Nation Observer

Subscribe Now
Log in
Menu
  • France
  • Europe
  • Switzerland
  • Business
  • International
  • Sports
  • UN
Home Switzerland

What will be the next obesity blockbuster?

cudhfrance@gmail.com by cudhfrance@gmail.com
April 22, 2026
in Switzerland
0
What will be the next obesity blockbuster?


The latest weight loss drugs like Wegovy and Mounjaro have changed the lives of many people with obesity. What will the next generation of obesity drugs look like?


This content was published on

April 22, 2026 – 11:50


I report on the Swiss pharmaceutical industry and healthcare topics such as access to medicine, biomedical innovation, and the impact of diseases like cancer.
I grew up just outside San Francisco and studied international affairs with a focus on development economics and healthcare policy. Prior to joining SWI swissinfo.ch in 2018, I was a freelance journalist and a researcher on business and human rights.




  • More from this author



  • English Department


My work focuses on engaging with you, our audience, and strengthening trust in our journalism. I develop engagement tools such as multilingual debates and help distribute our content to users across platforms.
A former nurse, I later pursued English linguistics and media studies where I developed a keen interest in journalism and news in the digital age.




  • More from this author



  • English Department

Two companies – Danish maker Novo Nordisk and US pharma company Eli Lilly – have dominated the market for obesity drugs.

But there are now dozens of big and small companies, including some Swiss ones, that are hoping to challenge them with a new generation of obesity drugs.

More

injection pen

More


New treatments

Can Swiss pharma giant Roche reshape the obesity market?




This content was published on

Apr 2, 2026


Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive market.



Read more: Can Swiss pharma giant Roche reshape the obesity market?

What are your thoughts or questions on weight loss drugs?

Articles in this story

Read More

Previous Post

Displaced Palestinians return to books as Gaza’s Phoenix library rises from the rubble

 Next Post

Enagás reduces net debt and maintains stable financial structure in Q1 2026
Next Post
Enagás reduces net debt and maintains stable financial structure in Q1 2026

Enagás reduces net debt and maintains stable financial structure in Q1 2026

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Israel's Benjamin Netanyahu treated for early-stage prostate cancer
  • AAP’s toughest phase: Why Raghav Chadha’s exit could reshape India’s youngest national party
  • MEPs in Rome to discuss Europe's future with the Pope
  • Weakening ocean currents could have intensified ice ages, Swiss study shows
  • Train indie ‘TGV Velvet’ unveils plans for west France rail services

Recent Comments

No comments to show.
Facebook X-twitter Youtube

Add New Playlist

No Result
View All Result
  • Cart
  • Checkout
  • Home
  • My account
  • Shop

© 2026 Nation Observer - Designed & Developed by Immanuel Kolwin.